Hepion Pharmaceuticals, Inc. (HEPA) Operating cash flow 2016–2025
Hepion Pharmaceuticals, Inc. (HEPA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.3MFY2025 · since FY2016: -$19.2M → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.3M | +82.0% |
| FY2024 | -$18.2M | +55.4% |
| FY2023 | -$40.9M | -17.0% |
| FY2022 | -$35.0M | -12.0% |
| FY2021 | -$31.2M | -93.2% |
| FY2020 | -$16.2M | -113.7% |
| FY2019 | -$7.6M | +51.6% |
| FY2018 | -$15.6M | — |
| FY2016 | -$19.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HEPA financial trends
HEPA RevenueHEPA Net incomeHEPA Net marginHEPA Gross profitHEPA Gross marginHEPA Operating incomeHEPA Operating marginHEPA Free cash flowHEPA Capital expendituresHEPA Return on equityHEPA Stock buybacksHEPA Dividends paidHEPA Total assetsHEPA Total liabilitiesHEPA Shareholders’ equityHEPA overview →